BP drug could prevent Alzheimer's

Use of the antihypertensive drug valsartan in elderly patients may also ward off Alzheimer's disease, suggest studies in mice.

Over two years, more than 1,500 medicines used for a range of conditions have been examined by US scientists to see if they could fight Alzheimer's.

As part of the study, 55 anti-hypertensives were tested on primary cortico-hippocampal neurons collected from Tg2576 mice, that were genetically engineered to develop Alzheimer's.

Of these, seven agents were able to reduce the beta-amyloid protein accumulation that is typically seen in Alzheimer's.

Only the angiotensin II antagonist valsartan was able to prevent beta-amyloid peptides clumping together. It is these high molecular weight oligomers that are known to lead to cognitive deterioration.

The researchers then gave Tg2576 mice valsartan. Neuropathology of Alzheimer's reduced when the drug was administered. The amount of high molecular weight oligomeric beta-amyloid peptides also decreased. This effect was still seen at half the dose of valsartan needed to control BP.

Latest findings back up observations of a reduced rate of Alzheimer's in elderly patients taking antihypertensive drugs.

Lead researcher Professor Giulia Maria Pasinetti, from Mount Sinai School of Medicine in New York, said: 'The use of these drugs for a potential anti-Alzheimer's disease role is still highly experimental and at this stage we have no clinical data beyond phenomenological observation in humans.'

Preventative and therapeutic clinical trials into the area are now needed, he added.

rachel.liddle@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

MPs demand urgent action on NHS backlog and routine COVID-19 tests for staff

MPs demand urgent action on NHS backlog and routine COVID-19 tests for staff

MPs have demanded urgent action to prevent avoidable harm to patients from the NHS...

Freeze QOF and deliver COVID cash or second wave will overwhelm GPs, BMA warns

Freeze QOF and deliver COVID cash or second wave will overwhelm GPs, BMA warns

GP practices will be unable to cope with a second wave of COVID-19 unless urgent...

Reducing our practice's carbon footprint by appropriate inhaler prescribing

Reducing our practice's carbon footprint by appropriate inhaler prescribing

Dr Vasu Siva explains how her practice is aiming to cut its carbon emissions by targeting...

RCGP chair warns of 'significant problem' over flu vaccine supplies

RCGP chair warns of 'significant problem' over flu vaccine supplies

The NHS faces a 'significant problem' with flu vaccine supplies as it aims to cover...

GMC overhauls consent advice to improve patient involvement in decisions about care

GMC overhauls consent advice to improve patient involvement in decisions about care

The GMC has overhauled its guidance on patient consent - setting out seven key principles...

Government must show evidence behind PPE strategy, warns BMA

Government must show evidence behind PPE strategy, warns BMA

Chronic shortages of personal protective equipment (PPE) across the NHS during the...